Cosmeceuticals Off the Face

  • Zoe Diana Draelos


Cosmeceuticals are a category of topical agents designed to improve the appearance of the skin. Traditionally, the cosmeceutical market has focused on products designed for facial application, yet the use of these topicals for body appearance improvement is rapidly increasing. Cosmeceuticals are substances found in both the over-the-counter (OTC) and prescription arena that can be effectively used by dermatologists to maintain or improve the results obtained with other rejuvenative procedures. Cosmeceuticals must be distinguished from colored cosmetics, designed only to adorn the body using pigments. The intent is that cosmeceuticals will produce an improvement in skin functioning by modifying texture, roughness, pigmentation, erythema, and desquamation. This chapter discusses how to use cosmeceuticals off the face.


Azelaic Acid Kojic Acid Retinyl Palmitate Licorice Extract Intercellular Lipid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



  1. 1.
    Willcox MJ, Crichton WP. The soap market. Cosmet Toilet. 1989;104:61–63.Google Scholar
  2. 2.
    Wortzman MS. Evaluation of mild skin cleansers. Derm Clinics. 1991;9:35–44.Google Scholar


  1. 3.
    Draelos ZD. Therapeutic moisturizers. Dermatol Clin. 2000;18:597–607.CrossRefPubMedGoogle Scholar
  2. 4.
    Flynn TC, Petros J, Clark RE, et al. Dry skin and moisturizers. Clin Dermatol. 2001;19:387–392.CrossRefPubMedGoogle Scholar
  3. 5.
    Rawlings AV, Harding CR, Watkinson A, Scott IR. Dry and xerotic skin conditions. In: Leyden JJ, Rawlings AV, eds. Skin Moisturization. New York:Marcel Dekker; 2002:119–144.Google Scholar
  4. 6.
    Draelos ZD. Moisturizers. In: Draelos ZD, ed. Cosmetics In Dermatology, 2nd edn. New York:Churchill-Livingstone; 1995:83–95.Google Scholar


  1. 7.
    Nash JF. Human safety and efficacy of ultraviolet filters and sunscreen products. Dermatol Clin. 2006;24:35–51.CrossRefPubMedGoogle Scholar
  2. 8.
    Gasparro FP, Mitchnick M, Nash JF. A review of sunscreen safety and efficacy. Photochem Photobiol. 1998;68:243–256.CrossRefPubMedGoogle Scholar
  3. 9.
    Moloney FJ, Collins S, Murphy GM. Sunscreens: safety, efficacy and appropriate use. Am J Clin Dermatol. 2002;3:185–191.CrossRefPubMedGoogle Scholar

Skin Lightening

  1. 10.
    Balina LM, Graupe K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol. 1991;30(12):893–895.CrossRefPubMedGoogle Scholar
  2. 11.
    Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Derm Surg. 1999;25:282–284.CrossRefGoogle Scholar
  3. 12.
    Hori I, Nihei K, Kubo I. Structural criteria for depigmenting mechanism of arbutin. Phytother Res. 2004;18:475–469.CrossRefPubMedGoogle Scholar
  4. 13.
    Amer M, Metwalli M. Topical Liquiritin improves melasma. Int J Dermatol. 2000;39(4):299–301.CrossRefPubMedGoogle Scholar


  1. 14.
    Glazier MG, Bowman MA. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med. 201;161:1161–1172.Google Scholar
  2. 15.
    Duell EA, Derguini F, Kang S, Elder JT, Voorhees JJ. Extraction of human epidermis treated with retinol yields retro-retinoids in addition to free retinol and retinyl esters. J Invest Dermatol. 1996;107:178–182.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Zoe Diana Draelos
    • 1
  1. 1.Department of DermatologyDuke University School of MedicineDurhamUSA

Personalised recommendations